KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Inventory: 2021-2025

Historic Change in Inventory for Novavax (NVAX) over the last 4 years, with Sep 2025 value amounting to $3.8 million.

  • Novavax's Change in Inventory rose 249.77% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 126.32%. This contributed to the annual value of -$12.9 million for FY2024, which is 117.34% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Change in Inventory is $3.8 million, which was down 6.41% from $4.0 million recorded in Q2 2025.
  • Novavax's Change in Inventory's 5-year high stood at $304.2 million during Q2 2022, with a 5-year trough of -$16.8 million in Q1 2024.
  • Over the past 3 years, Novavax's median Change in Inventory value was $2.6 million (recorded in 2024), while the average stood at $6.1 million.
  • In the last 5 years, Novavax's Change in Inventory surged by 478.62% in 2022 and then plummeted by 282.38% in 2024.
  • Over the past 5 years, Novavax's Change in Inventory (Quarterly) stood at $8.9 million in 2021, then skyrocketed by 478.62% to $51.3 million in 2022, then plummeted by 115.75% to -$8.1 million in 2023, then skyrocketed by 102.34% to $189,000 in 2024, then skyrocketed by 249.77% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $4.0 million for Q2 2025, and -$2.4 million during Q1 2025.